A Phase I Study of TS-1, Cisplatin & RAD001 (Everolimus).

Trial Profile

A Phase I Study of TS-1, Cisplatin & RAD001 (Everolimus).

Discontinued
Phase of Trial: Phase I

Latest Information Update: 21 Feb 2014

At a glance

  • Drugs Everolimus (Primary) ; Cisplatin; Gimeracil/oteracil/tegafur
  • Indications Solid tumours
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 Feb 2014 Status changed from not yet recruiting to discontinued.
    • 05 Apr 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top